The DOI matches its Crossref record; 131 of the 131 references it cites were found in a registry or an index.
The pathogenesis of insulin resistance: integrating signaling pathways and substrate flux
Open accessAbstract
Insulin resistance arises when the nutrient storage pathways evolved to maximize efficient energy utilization are exposed to chronic energy surplus. Ectopic lipid accumulation in liver and skeletal muscle triggers pathways that impair insulin signaling, leading to reduced muscle glucose uptake and decreased hepatic glycogen synthesis. Muscle insulin resistance, due to ectopic lipid, precedes liver insulin resistance and diverts ingested glucose to the liver, resulting in increased hepatic de novo lipogenesis and hyperlipidemia. Subsequent macrophage infiltration into white adipose tissue (WAT) leads to increased lipolysis, which further increases hepatic triglyceride synthesis and hyperlipidemia due to increased fatty acid esterification. Macrophage-induced WAT lipolysis also stimulates hepatic gluconeogenesis, promoting fasting and postprandial hyperglycemia through increased fatty acid delivery to the liver, which results in increased hepatic acetyl-CoA content, a potent activator of pyruvate carboxylase, and increased glycerol conversion to glucose. These substrate-regulated processes are mostly independent of insulin signaling in the liver but are dependent on insulin signaling in WAT, which becomes defective with inflammation. Therapies that decrease ectopic lipid storage and diminish macrophage-induced WAT lipolysis will reverse the root causes of type 2 diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Supporting this perspective, monosaccharides have been shown to activate ChREBP and other key lipogenic transcription factors—including SREBP1c, LXR, and PPARγ—via insulin-independent mechanisms [34,70,83,86,99].”
From Hepatic Insulin Resistance and Steatosis in Metabolic Dysfunction-Associated Steatotic Liver Disease: New Insights into Mechanisms and Clinical Implications (2025) · cites this paper as [99]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In both animal models and human patients, obesity‐induced hyperlipidaemia and lipotoxicity‐induced inflammation is thought to be one of the drivers for SO.[ 63 ]”
From Pathogenesis of sarcopenia and the relationship with fat mass: descriptive review (2022) · cites this paper as [63]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“In lipid infusion experiments, DAG content in the muscle increases, and consequently PKCθ is activated, resulting in limited phosphorylation of IRS-1 and glucose uptake through GLUT4 [9].”
From Sarcopenic obesity, insulin resistance, and their implications in cardiovascular and metabolic consequences (2020) · cites this paper as [9]
In the citing paper
“Insulin resistance is the core mechanism of sarcopenic obesity and is also associated with variable cardiometabolic diseases such as cardiovascular disease, type 2 diabetes mellitus, and non-alcoholic fatty liver disease.”
From Sarcopenic obesity, insulin resistance, and their implications in cardiovascular and metabolic consequences (2020) · cites this paper as [9]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Obesity is associated with macrophage accumulation in adipose tissue
Weisberg, S. P., McCann, D., Desai, M., Rosenbaum, M., Leibel, R. L., & Ferrante, A. W. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200319246 · Cited by 10,041 · cited 1×
“Activated adipose tissue macrophages (ATMs) are recruited via chemokine signaling (96, 97) and release cytokines that promote lipolysis.”
BackgroundThe metabolic phenotype in obesity: Fat mass, body fat distribution, and adipose tissue function
Goossens, G. H. (2017) · Obesity Facts · doi:10.1159/000471488 · Cited by 8,481
Xu, H., Barnes, G. T., Yang, Q., Tan, G., Yang, D., Chou, C. J., Sole, J., Nichols, A., Ross, J. S., Tartaglia, L. A., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200319451 · Cited by 6,760 · cited 1×
“Activated adipose tissue macrophages (ATMs) are recruited via chemokine signaling (96, 97) and release cytokines that promote lipolysis.”
BackgroundLippa, N. C., & Sanderson, S. C. (2013) · Human Heredity · doi:10.1159/000353712 · Cited by 6,078
Adipose Tissue as an Endocrine Organ
Kershaw, E. E., & Flier, J. S. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0395 · Cited by 5,522
Randle, P. J., Garland, P. B., Hales, C. N., & Newsholme, E. A. (1963) · The Lancet · doi:10.1016/s0140-6736(63)91500-9 · Cited by 5,093 · cited 2×
“Over a half century ago, Randle and colleagues concluded that muscle insulin resistance associated with obesity could be attributed to increased fatty acid oxidation that limits insulin-stimulated glucose utilization (43).”
BackgroundGenetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease
Romeo, S., Kozlitina, J., Xing, C., Pertsemlidis, A., Cox, D., Pennacchio, L. A., Boerwinkle, E., Cohen, J. C., & Hobbs, H. H. (2008) · Nature Genetics · doi:10.1038/ng.257 · Cited by 3,416 · cited 1×
“A common single nucleotide polymorphism (rs738409, I48M) in the lipid droplet protein patatin-like phospholipase domaincontaining protein 3 (PNPLA3, also called adiponutrin) has been associated with increased hepatic steatosis but not insulin resistance (74).”
BackgroundKim, H. J., Park, S. Y., Choi, Y. J., Han, S. J., Lee, K. W., & Kim, D. J. (2013) · Hormone Research in Paediatrics · doi:10.1159/000348848 · Cited by 3,048
Defining the role of mTOR in cancer
Guertin, D. A., & Sabatini, D. M. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.05.008 · Cited by 2,833 · cited 1×
“Insulin activates the insulin receptor tyrosine kinase (IRTK), with subsequent activation of kinases including 3-phosphoinositide-dependent kinase-1 (PDK1) and mTORC2 (6), which converge on Akt phosphorylation (6–8).”
BackgroundAlessi, D. R., James, S. R., Downes, C. P., Holmes, A. B., Gaffney, P. R. J., Reese, C. B., & Cohen, P. (1997) · Current Biology · doi:10.1016/s0960-9822(06)00122-9 · Cited by 2,826
Mechanisms for Insulin Resistance: Common Threads and Missing Links
Samuel, V. T., & Shulman, G. I. (2012) · Cell · doi:10.1016/j.cell.2012.02.017 · Cited by 2,294
Self-citationImpaired Mitochondrial Activity in the Insulin-Resistant Offspring of Patients with Type 2 Diabetes
Petersen, K. F., Dufour, S., Befroy, D., Garcia, R., & Shulman, G. I. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa031314 · Cited by 2,193 · cited 1×
“Muscle mitochondrial oxidative and phosphorylation activity were also reduced by approximately 40% in healthy, young, lean, insulin-resistant offspring of patients with T2DM (52, 53).”
BackgroundSelf-citationMitochondrial dysfunction in the elderly: possible role in insulin resistance
Petersen, K. F., Befroy, D., Dufour, S., Dziura, J., Ariyan, C., Rothman, D. L., DiPietro, L., Cline, G. W., & Shulman, G. I. (2003) · Science · doi:10.1126/science.1082889 · Cited by 2,107 · cited 1×
“Ageassociated reductions in mitochondrial function may be due to cumulative damage from ROS (50).”
BackgroundSelf-citationStanhope, K. L., Schwarz, J. M., Keim, N. L., Griffen, S. C., Bremer, A. A., Graham, J. L., Hatcher, B., Cox, C. L., Dyachenko, A., Zhang, W., et al. (2009) · Journal of Clinical Investigation · doi:10.1172/jci37385 · Cited by 1,765 · cited 1×
“Human subjects who consumed fructose-containing beverages, in comparison with those consuming isocaloric glucose-containing beverages, developed hyperlipidemia and insulin resistance despite gaining a similar amount of weight (113).”
BackgroundYu, C., Chen, Y., Cline, G. W., Zhang, D., Zong, H., Wang, Y., Bergeron, R., Kim, J. K., Cushman, S. W., Cooney, G. J., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200958200 · Cited by 1,561 · cited 2×
“In rodents, lipid infusion and high-fat feeding led to transient increases in muscle DAG content (56), resulting in sustained activation of PKCθ that limited phosphorylation of IRS-1 by IRTK (Figure 2).”
BackgroundSelf-citationMechanism of free fatty acid-induced insulin resistance in humans.
Roden, M., Price, T. B., Perseghin, G., Petersen, K. F., Rothman, D. L., Cline, G. W., & Shulman, G. I. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118742 · Cited by 1,539 · cited 1×
“Yet, noninvasive measurements of these metabolites by 13C and 31P MRS studies found that the intramyocellular concentrations of these metabolites were decreased in human muscle during the acute induction of insulin resistance by a lipid infusion, demonstrating that fatty acids impair insulin-stimulated glucose metabol…”
BackgroundSelf-citationItani, S. I., Ruderman, N. B., Schmieder, F., & Boden, G. (2002) · Diabetes · doi:10.2337/diabetes.51.7.2005 · Cited by 1,390
Mechanism of hepatic insulin resistance in non-alcoholic fatty liver disease
Samuel, V. T., Liu, Z.-X., Qu, X., Elder, B. D., Bilz, S., Befroy, D., Romanelli, A. J., & Shulman, G. I. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m313478200 · Cited by 1,322 · cited 1×
“In fat-fed rats, the increase in hepatic DAG content activates PKCε, the primary PKC isoform in liver (66, 67).”
BackgroundSelf-citationDresner, A., Laurent, D., Marcucci, M., Griffin, M. E., Dufour, S., Cline, G. W., Slezak, L. A., Andersen, D. K., Hundal, R. S., Rothman, D. L., et al. (1999) · Journal of Clinical Investigation · doi:10.1172/jci5001 · Cited by 1,311 · cited 3×
“Insulin-stimulated tyrosine phosphorylation of IRS-1 and IRS-1–associated PI3K activation were acutely impaired in skeletal muscle of lipid-infused humans (45) and rodents (56, 57).”
BackgroundSelf-citationObesity-associated improvements in metabolic profile through expansion of adipose tissue
Kim, J.-Y., van de Wall, E., Laplante, M., Azzara, A., Trujillo, M. E., Hofmann, S. M., Schraw, T., Durand, J. L., Li, H., Li, G., et al. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31021 · Cited by 1,310 · cited 1×
“While overexpression of adiponectin in ob/ob mice leads to increased adiposity, the improvement in adipose function lowered adipose inflammation, circulating lipids, and hepatic DAG content and improved hepatic insulin action (93).”
BackgroundSelf-citationBoyle, J. P., Thompson, T. J., Gregg, E. W., Barker, L. E., & Williamson, D. F. (2010) · Population Health Metrics · doi:10.1186/1478-7954-8-29 · Cited by 1,309 · cited 1×
“This knowledge and understanding gained over the past several decades into the pathogenesis of insulin resistance may avert the looming epidemics of diabetes and NAFLD/NASH and ensure a healthier future for subsequent generations (130).”
BackgroundGriffin, M. E., Marcucci, M. J., Cline, G. W., Bell, K., Barucci, N., Lee, D., Goodyear, L. J., Kraegen, E. W., White, M. F., & Shulman, G. I. (1999) · Diabetes · doi:10.2337/diabetes.48.6.1270 · Cited by 1,267
Self-citationKrssak, M., Falk Petersen, K., Dresner, A., DiPietro, L., Vogel, S. M., Rothman, D. L., Shulman, G. I., & Roden, M. (1999) · Diabetologia · doi:10.1007/s001250051123 · Cited by 1,264 · cited 1×
“1H MRS studies have demonstrated that intramyocellular lipid (IMCL) content is a much better predictor of muscle insulin resistance than fat mass in healthy, young, sedentary, lean individuals (40) and nonobese, nondiabetic but insulinresistant adults (41) and children (42), suggesting a potential causal role for IMCL…”
BackgroundSelf-citationAdipose-selective targeting of the GLUT4 gene impairs insulin action in muscle and liver
Abel, E. D., Peroni, O., Kim, J. K., Kim, Y.-B., Boss, O., Hadro, E., Minnemann, T., Shulman, G. I., & Kahn, B. B. (2001) · Nature · doi:10.1038/35055575 · Cited by 1,253 · cited 1×
“For example, loss of adipose GLUT4 in mice does not alter adiposity or weight gain but leads to insulin resistance in skeletal muscle and liver (84).”
BackgroundSelf-citationHolland, W. L., Brozinick, J. T., Wang, L.-P., Hawkins, E. D., Sargent, K. M., Liu, Y., Narra, K., Hoehn, K. L., Knotts, T. A., Siesky, A., et al. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2007.01.002 · Cited by 1,232 · cited 1×
“org Volume 126 Number 1 January 2016 resistance in rodents (78), and inhibitors of ceramide synthesis can prevent insulin resistance (79, 80).”
BackgroundLim, E. L., Hollingsworth, K. G., Aribisala, B. S., Chen, M. J., Mathers, J. C., & Taylor, R. (2011) · Diabetologia · doi:10.1007/s00125-011-2204-7 · Cited by 1,164 · cited 14×
“Proof-of-concept studies in rodent models of NALFD and T2D demonstrate that mildly increasing hepatic mitochondrial inefficiency can safely reverse hypertriglyceridemia, ectopic lipid-induced (DAG/nPKC) liver and muscle insulin resistance, steatohepatitis, liver fibrosis, and diabetes, offering a novel therapeutic tar…”
BackgroundInfluentialIdentification of a Lipokine, a Lipid Hormone Linking Adipose Tissue to Systemic Metabolism
Cao, H., Gerhold, K., Mayers, J. R., Wiest, M. M., Watkins, S. M., & Hotamisligil, G. S. (2008) · Cell · doi:10.1016/j.cell.2008.07.048 · Cited by 1,139 · cited 1×
“Adipocytes release specific fatty acids that are associated with increased insulin sensitivity, like palmitoleate (86, 87) or monomethyl branched chain fatty acids (88).”
BackgroundStephens, L., Anderson, K., Stokoe, D., Erdjument-Bromage, H., Painter, G. F., Holmes, A. B., Gaffney, P. R. J., Reese, C. B., McCormick, F., Tempst, P., et al. (1998) · Science · doi:10.1126/science.279.5351.710 · Cited by 1,059
Insulin-stimulated Phosphorylation of a Rab GTPase-activating Protein Regulates GLUT4 Translocation
Sano, H., Kane, S., Sano, E., Mı̂inea, C. P., Asara, J. M., Lane, W. S., Garner, C. W., & Lienhard, G. E. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.c300063200 · Cited by 962
Petersen, K. F., Dufour, S., Befroy, D., Lehrke, M., Hendler, R. E., & Shulman, G. I. (2005) · Diabetes · doi:10.2337/diabetes.54.3.603 · Cited by 911
Self-citationThe effects of LY2405319, an FGF21 analog, in obese human subjects with type 2 diabetes
Gaich, G., Chien, J. Y., Fu, H., Glass, L. C., Deeg, M. A., Holland, W. L., Kharitonenkov, A., Bumol, T., Schilske, H. K., & Moller, D. E. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.08.005 · Cited by 885 · cited 1×
“In this regard, FGF-21 has been shown to be effective in reducing hepatic steatosis and reversing insulin resistance in rodents (124) and is now in clinical trials (125).”
BackgroundPerseghin, G., Scifo, P., De Cobelli, F., Pagliato, E., Battezzati, A., Arcelloni, C., Vanzulli, A., Testolin, G., Pozza, G., Del Maschio, A., et al. (1999) · Diabetes · doi:10.2337/diabetes.48.8.1600 · Cited by 877 · cited 1×
“1H MRS studies have demonstrated that intramyocellular lipid (IMCL) content is a much better predictor of muscle insulin resistance than fat mass in healthy, young, sedentary, lean individuals (40) and nonobese, nondiabetic but insulinresistant adults (41) and children (42), suggesting a potential causal role for IMCL…”
BackgroundDiscovery of a Class of Endogenous Mammalian Lipids with Anti-Diabetic and Anti-inflammatory Effects
Yore, M. M., Syed, I., Moraes-Vieira, P. M., Zhang, T., Herman, M. A., Homan, E. A., Patel, R. T., Lee, J., Chen, S., Peroni, O. D., et al. (2014) · Cell · doi:10.1016/j.cell.2014.09.035 · Cited by 842 · cited 2×
“Recently, ChREBP was implicated in the synthesis of fatty acid esters of hydroxy fatty acids (FAHFAs), which improve glucose tolerance (89).”
BackgroundMorino, K. (2005) · Journal of Clinical Investigation · doi:10.1172/jci25151 · Cited by 811 · cited 1×
“In contrast to aging, these reductions in mitochondrial activity appear to be secondary to reduction in mitochondrial density (54) and may be due in part to diminished expression of LpL in skeletal muscle, which could limit PPARδ-mediated mitochondrial biogenesis (55).”
BackgroundLeptin reverses insulin resistance and hepatic steatosis in patients with severe lipodystrophy
Petersen, K. F., Oral, E. A., Dufour, S., Befroy, D., Ariyan, C., Yu, C., Cline, G. W., DePaoli, A. M., Taylor, S. I., Gorden, P., et al. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215001 · Cited by 800 · cited 3×
“Leptin therapy reduced calorie intake, resolved hepatic steatosis, and improved insulin action (63).”
BackgroundSelf-citationThe role of skeletal muscle insulin resistance in the pathogenesis of the metabolic syndrome
Petersen, K. F., Dufour, S., Savage, D. B., Bilz, S., Solomon, G., Yonemitsu, S., Cline, G. W., Befroy, D., Zemany, L., Kahn, B. B., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0705408104 · Cited by 759
Self-citationTissue-specific overexpression of lipoprotein lipase causes tissue-specific insulin resistance
Kim, J. K., Fillmore, J. J., Chen, Y., Yu, C., Moore, I. K., Pypaert, M., Lutz, E. P., Kako, Y., Velez-Carrasco, W., Goldberg, I. J., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.121164498 · Cited by 753 · cited 1×
“Similarly, mice overexpressing LpL in the liver develop hepatic steatosis and liver-specific insulin resistance (65).”
BackgroundSelf-citationPerry, R. J., Camporez, J.-P. G., Kursawe, R., Titchenell, P. M., Zhang, D., Perry, C. J., Jurczak, M. J., Abudukadier, A., Han, M. S., Zhang, X.-M., et al. (2015) · Cell · doi:10.1016/j.cell.2015.01.012 · Cited by 719 · cited 2×
“First, lipolysis increases fatty acid delivery to the liver, leading to increased hepatic acetyl-CoA content, which activates PC activity and PC flux (17, 18).”
BackgroundSelf-citationPerseghin, G., Price, T. B., Petersen, K. F., Roden, M., Cline, G. W., Gerow, K., Rothman, D. L., & Shulman, G. I. (1996) · New England Journal of Medicine · doi:10.1056/nejm199610313351804 · Cited by 699 · cited 2×
“Similar reductions in glucose transport were observed in insulin-resistant, obese individuals (46); patients with T2D (47); and lean, normoglycemic but insulin-resistant offspring of T2D parents (48).”
BackgroundSelf-citationTurpin, S. M., Nicholls, H. T., Willmes, D. M., Mourier, A., Brodesser, S., Wunderlich, C. M., Mauer, J., Xu, E., Hammerschmidt, P., Brönneke, H. S., et al. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2014.08.002 · Cited by 691
Cline, G. W., Petersen, K. F., Krssak, M., Shen, J., Hundal, R. S., Trajanoski, Z., Inzucchi, S., Dresner, A., Rothman, D. L., & Shulman, G. I. (1999) · New England Journal of Medicine · doi:10.1056/nejm199907223410404 · Cited by 675 · cited 2×
“Similar reductions in glucose transport were observed in insulin-resistant, obese individuals (46); patients with T2D (47); and lean, normoglycemic but insulin-resistant offspring of T2D parents (48).”
BackgroundSelf-citationGlucagonocentric restructuring of diabetes: A pathophysiologic and therapeutic makeover
Unger, R. H., & Cherrington, A. D. (2012) · Journal of Clinical Investigation · doi:10.1172/jci60016 · Cited by 670 · cited 1×
“Leptin clearly has pleiotropic effects on glucose metabolism, including reduction in food intake, which reduces ectopic lipid accumulation and improves hepatic and muscle insulin action in lipodystrophic individuals (63); reduction of glucagon secretion (104); neural regulation of hepatic glucose production (105); and…”
BackgroundNawrocki, A. R., Rajala, M. W., Tomas, E., Pajvani, U. B., Saha, A. K., Trumbauer, M. E., Pang, Z., Chen, A. S., Ruderman, N. B., Chen, H., et al. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m505311200 · Cited by 639 · cited 1×
“Mice lacking adiponectin are prone to hepatic steatosis and hepatic insulin resistance (91, 92).”
BackgroundA novel ChREBP isoform in adipose tissue regulates systemic glucose metabolism
Herman, M. A., Peroni, O. D., Villoria, J., Schön, M. R., Abumrad, N. A., Blüher, M., Klein, S., & Kahn, B. B. (2012) · Nature · doi:10.1038/nature10986 · Cited by 596 · cited 2×
“Intriguingly, adipose ChREBP expression appears directly related to insulin sensitivity in humans (85).”
BackgroundCellular mechanism of insulin resistance in nonalcoholic fatty liver disease
Kumashiro, N., Erion, D. M., Zhang, D., Kahn, M., Beddow, S. A., Chu, X., Still, C. D., Gerhard, G. S., Han, X., Dziura, J., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1113359108 · Cited by 585 · cited 2×
“However, a disassociation between ceramide content and tissue insulin resistance has been reported in multiple studies (70, 71, 81), and the underlying mechanism linking ceramides to insulin resistance has not been fully resolved.”
BackgroundSelf-citationPhysiological regulation of lipoprotein lipase
Kersten, S. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2014.03.013 · Cited by 550 · cited 1×
“Whereas insulin regulates basal LpL expression, a number of other proteins regulate LpL activity (38).”
BackgroundUyeda, K., & Repa, J. J. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.06.008 · Cited by 529 · cited 6×
“Glucose entry into adipose cells activates carbohydrate response element binding protein (ChREBP), which may impact adipose lipid metabolism (85).”
BackgroundInfluentialSamuel, V. T., Liu, Z.-X., Wang, A., Beddow, S. A., Geisler, J. G., Kahn, M., Zhang, X.-M., Monia, B. P., Bhanot, S., & Shulman, G. I. (2007) · Journal of Clinical Investigation · doi:10.1172/jci30400 · Cited by 497
Self-citationSinha, R., Dufour, S., Petersen, K. F., LeBon, V., Enoksson, S., Ma, Y.-Z., Savoye, M., Rothman, D. L., Shulman, G. I., & Caprio, S. (2002) · Diabetes · doi:10.2337/diabetes.51.4.1022 · Cited by 493 · cited 1×
“1H MRS studies have demonstrated that intramyocellular lipid (IMCL) content is a much better predictor of muscle insulin resistance than fat mass in healthy, young, sedentary, lean individuals (40) and nonobese, nondiabetic but insulinresistant adults (41) and children (42), suggesting a potential causal role for IMCL…”
BackgroundSelf-citationPersonal Responsibility And Obesity: A Constructive Approach To A Controversial Issue
Brownell, K. D., Kersh, R., Ludwig, D. S., Post, R. C., Puhl, R. M., Schwartz, M. B., & Willett, W. C. (2010) · Health Affairs · doi:10.1377/hlthaff.2009.0739 · Cited by 459 · cited 14×
“Proof-of-concept studies in rodent models of NALFD and T2D demonstrate that mildly increasing hepatic mitochondrial inefficiency can safely reverse hypertriglyceridemia, ectopic lipid-induced (DAG/nPKC) liver and muscle insulin resistance, steatohepatitis, liver fibrosis, and diabetes, offering a novel therapeutic tar…”
BackgroundInfluentialRaichur, S., Wang, S. T., Chan, P. W., Li, Y., Ching, J., Chaurasia, B., Dogra, S., Öhman, M. K., Takeda, K., Sugii, S., et al. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2014.09.015 · Cited by 455 · cited 1×
“Recently, two studies examined how a specific ceramide species, C16:0, impedes mitochondrial function, allowing triglyceride accumulation and insulin resistance (82, 83).”
BackgroundBefroy, D. E., Petersen, K. F., Dufour, S., Mason, G. F., de Graaf, R. A., Rothman, D. L., & Shulman, G. I. (2007) · Diabetes · doi:10.2337/db06-0783 · Cited by 453 · cited 1×
“Muscle mitochondrial oxidative and phosphorylation activity were also reduced by approximately 40% in healthy, young, lean, insulin-resistant offspring of patients with T2DM (52, 53).”
BackgroundSelf-citationSavage, D. B. (2006) · Journal of Clinical Investigation · doi:10.1172/jci27300 · Cited by 447
Mechanism of Insulin Resistance in A-ZIP/F-1 Fatless Mice
Kim, J. K., Gavrilova, O., Chen, Y., Reitman, M. L., & Shulman, G. I. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.12.8456 · Cited by 443 · cited 1×
“Lipodystrophic mice have a similar phenotype, and fat transplantation rescued these mice by allowing a redistribution of lipids from ectopic sites to transplanted adipose tissue and normalization of insulin action (64).”
BackgroundSelf-citationThe Disposal of an Oral Glucose Load in Healthy Subjects: A Quantitative Study
Ferrannini, E., Bjorkman, O., Reichard, G. A., Pilo, A., Olsson, M., Wahren, J., & DeFronzo, R. A. (1985) · Diabetes · doi:10.2337/diab.34.6.580 · Cited by 439
Apolipoprotein C3 gene variants in nonalcoholic fatty liver disease
Petersen, K. F., Dufour, S., Hariri, A., Nelson-Williams, C., Foo, J. N., Zhang, X.-M., Dziura, J., Lifton, R. P., & Shulman, G. I. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0907295 · Cited by 428
Self-citationRole of diacylglycerol activation of PKCθ in lipid-induced muscle insulin resistance in humans
Szendroedi, J., Yoshimura, T., Phielix, E., Koliaki, C., Marcucci, M., Zhang, D., Jelenik, T., Müller, J., Herder, C., Nowotny, P., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1409229111 · Cited by 415
Self-citationO'Neill, H. M., Maarbjerg, S. J., Crane, J. D., Jeppesen, J., Jørgensen, S. B., Schertzer, J. D., Shyroka, O., Kiens, B., van Denderen, B. J., Tarnopolsky, M. A., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1105062108 · Cited by 406 · cited 1×
“Muscle contraction activates AMPK, which phosphorylates proteins that regulate GSV translocation (29).”
BackgroundIncreased prevalence of insulin resistance and nonalcoholic fatty liver disease in Asian-Indian men
Petersen, K. F., Dufour, S., Feng, J., Befroy, D., Dziura, J., Man, C. D., Cobelli, C., & Shulman, G. I. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0608537103 · Cited by 403 · cited 1×
“However, muscle insulin resistance, which occurs early in the course of T2D (47), increases glucose delivery to the liver, where the lipogenic machinery has been primed by chronic hyperinsulinemia (110).”
BackgroundSelf-citationInsulin regulates liver metabolism in vivo in the absence of hepatic Akt and Foxo1
Lu, M., Wan, M., Leavens, K. F., Chu, Q., Monks, B. R., Fernandez, S., Ahima, R. S., Ueki, K., Kahn, C. R., & Birnbaum, M. J. (2012) · Nature Medicine · doi:10.1038/nm.2686 · Cited by 395 · cited 1×
“Hepatic insulin resistance in mice lacking both hepatic Akt1 and Akt2 (double liver KO; DLKO) was essentially normalized by the additional deletion of FOXO1, in a triple KO (TLKO) mouse model (11).”
BackgroundRaichur, S., Wang, S. T., Chan, P. W., Li, Y., Ching, J., Chaurasia, B., Dogra, S., Öhman, M. K., Takeda, K., Sugii, S., et al. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2014.10.007 · Cited by 385
Pnpla3I148M knockin mice accumulate PNPLA3 on lipid droplets and develop hepatic steatosis
Smagris, E., BasuRay, S., Li, J., Huang, Y., Lai, K. V., Gromada, J., Cohen, J. C., & Hobbs, H. H. (2015) · Hepatology · doi:10.1002/hep.27242 · Cited by 379 · cited 2×
“Mice expressing the knock-in mutation develop dietinduced steatosis with normal glucose tolerance (75).”
BackgroundMetabolic defects in lean nondiabetic offspring of NIDDM parents: a cross-sectional study
Perseghin, G., Ghosh, S., Gerow, K., & Shulman, G. I. (1997) · Diabetes · doi:10.2337/diab.46.6.1001 · Cited by 367
Self-citationUssher, J. R., Koves, T. R., Cadete, V. J. J., Zhang, L., Jaswal, J. S., Swyrd, S. J., Lopaschuk, D. G., Proctor, S. D., Keung, W., Muoio, D. M., et al. (2010) · Diabetes · doi:10.2337/db09-1293 · Cited by 362 · cited 1×
“org Volume 126 Number 1 January 2016 resistance in rodents (78), and inhibitors of ceramide synthesis can prevent insulin resistance (79, 80).”
BackgroundFried, S. K., Russell, C. D., Grauso, N. L., & Brolin, R. E. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116821 · Cited by 358 · cited 1×
“adipose tissues (35), while insulin resistance in humans is associated with a decrease in s.”
BackgroundExercise and type 2 diabetes: molecular mechanisms regulating glucose uptake in skeletal muscle
Stanford, K. I., & Goodyear, L. J. (2014) · Advances in Physiology Education · doi:10.1152/advan.00080.2014 · Cited by 348
Kim, J. K., Michael, M. D., Previs, S. F., Peroni, O. D., Mauvais-Jarvis, F., Neschen, S., Kahn, B. B., Kahn, C. R., & Shulman, G. I. (2000) · Journal of Clinical Investigation · doi:10.1172/jci8305 · Cited by 331 · cited 8×
“Mice with targeted deletion of the insulin receptor in skeletal muscle have impaired insulininduced muscle glucose uptake (27) but have normal exercise-induced muscle glucose uptake (28).”
BackgroundInfluentialSelf-citationLee, H.-Y., Choi, C. S., Birkenfeld, A. L., Alves, T. C., Jornayvaz, F. R., Jurczak, M. J., Zhang, D., Woo, D. K., Shadel, G. S., Ladiges, W., et al. (2010) · Cell Metabolism · doi:10.1016/j.cmet.2010.11.004 · Cited by 319 · cited 1×
“Supporting this hypothesis, transgenic mice that overexpress a mitochondrial-targeted form of human catalase were protected from mitochondrial oxidative damage associated with aging and were able to maintain normal muscle mitochondrial function, muscle triglyceride/diacylglycerol (DAG) content and insulin action (51).”
BackgroundSelf-citationVirtanen, K. A., Lönnroth, P., Parkkola, R., Peltoniemi, P., Asola, M., Viljanen, T., Tolvanen, T., Knuuti, J., Rönnemaa, T., Huupponen, R., et al. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.87.8.3902 · Cited by 315
Regulation of Triglyceride Metabolism.IV. Hormonal regulation of lipolysis in adipose tissue
Jaworski, K., Sarkadi-Nagy, E., Duncan, R. E., Ahmadian, M., & Sul, H. S. (2007) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00554.2006 · Cited by 300
Rebrin, K., Steil, G. M., Mittelman, S. D., & Bergman, R. N. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118846 · Cited by 289 · cited 1×
“Bergman and others postulated that insulin’s ability to suppress hepatic glucose production was linked to the suppression of adipose lipolysis (16).”
BackgroundNiclosamide ethanolamine–induced mild mitochondrial uncoupling improves diabetic symptoms in mice
Tao, H., Zhang, Y., Zeng, X., Shulman, G. I., & Jin, S. (2014) · Nature Medicine · doi:10.1038/nm.3699 · Cited by 288
Self-citationControlled-release mitochondrial protonophore reverses diabetes and steatohepatitis in rats
Perry, R. J., Zhang, D., Zhang, X.-M., Boyer, J. L., & Shulman, G. I. (2015) · Science · doi:10.1126/science.aaa0672 · Cited by 283 · cited 3×
“The importance of intrahepatic DAG and acetyl-CoA in promoting hepatic insulin resistance and increased hepatic gluconeogenesis was also demonstrated in rats treated with either a liver-targeted or controlled release formulation of a mitochondrial protonophore (81, 118).”
BackgroundRegulation of Glucose Transporter Translocation in Health and Diabetes
Bogan, J. S. (2012) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-060109-094246 · Cited by 279
Bruss, M. D., Arias, E. B., Lienhard, G. E., & Cartee, G. D. (2005) · Diabetes · doi:10.2337/diabetes.54.1.41 · Cited by 273
1,2-Diacylglycerol and ceramide levels in insulin-resistant tissues of the rat in vivo.
Turinsky, J., O'Sullivan, D. M., & Bayly, B. P. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)44844-7 · Cited by 269 · cited 1×
“org Volume 126 Number 1 January 2016 resistance in rodents (78), and inhibitors of ceramide synthesis can prevent insulin resistance (79, 80).”
BackgroundTaylor, E. B., An, D., Kramer, H. F., Yu, H., Fujii, N. L., Roeckl, K. S. C., Bowles, N., Hirshman, M. F., Xie, J., Feener, E. P., et al. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m708839200 · Cited by 269 · cited 2×
“20, 21) and TBC1D1 (22), which increase glucose transporter type 4–containing (GLUT4containing) storage vesicles (GSVs) trafficking to the plasma membrane, cellular glucose transport, and glycogen synthesis.”
BackgroundBrain Insulin Controls Adipose Tissue Lipolysis and Lipogenesis
Scherer, T., O'Hare, J., Diggs-Andrews, K., Schweiger, M., Cheng, B., Lindtner, C., Zielinski, E., Vempati, P., Su, K., Dighe, S., et al. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2011.01.008 · Cited by 262
Mechanism by which glucose and insulin inhibit net hepatic glycogenolysis in humans.
Petersen, K. F., Laurent, D., Rothman, D. L., Cline, G. W., & Shulman, G. I. (1998) · Journal of Clinical Investigation · doi:10.1172/jci579 · Cited by 237 · cited 5×
“Insulin is a crucial regulator of this transition, primarily by activating glycogen synthase (1).”
BackgroundInfluentialSelf-citationWojtaszewski, J. F. P., Higaki, Y., Hirshman, M. F., Michael, M. D., Dufresne, S. D., Kahn, C. R., & Goodyear, L. J. (1999) · Journal of Clinical Investigation · doi:10.1172/jci7961 · Cited by 235 · cited 1×
“Mice with targeted deletion of the insulin receptor in skeletal muscle have impaired insulininduced muscle glucose uptake (27) but have normal exercise-induced muscle glucose uptake (28).”
BackgroundInsulin-independent regulation of hepatic triglyceride synthesis by fatty acids
Vatner, D. F., Majumdar, S. K., Kumashiro, N., Petersen, M. C., Rahimi, Y., Gattu, A. K., Bears, M., Camporez, J.-P. G., Cline, G. W., Jurczak, M. J., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1423952112 · Cited by 235 · cited 1×
“hypothesized that hepatic triglyceride synthesis could be driven by substrate (fatty acids), independent of changes in hepatic insulin signaling (109).”
BackgroundSelf-citationPerry, R. J., Kim, T., Zhang, X.-M., Lee, H.-Y., Pesta, D., Popov, V. B., Zhang, D., Rahimi, Y., Jurczak, M. J., Cline, G. W., et al. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.10.004 · Cited by 230 · cited 4×
“However, a disassociation between ceramide content and tissue insulin resistance has been reported in multiple studies (70, 71, 81), and the underlying mechanism linking ceramides to insulin resistance has not been fully resolved.”
BackgroundInfluentialSelf-citationCellular Mechanisms by Which FGF21 Improves Insulin Sensitivity in Male Mice
Camporez, J. P. G., Jornayvaz, F. R., Petersen, M. C., Pesta, D., Guigni, B. A., Serr, J., Zhang, D., Kahn, M., Samuel, V. T., Jurczak, M. J., et al. (2013) · Endocrinology · doi:10.1210/en.2013-1191 · Cited by 228 · cited 1×
“In this regard, FGF-21 has been shown to be effective in reducing hepatic steatosis and reversing insulin resistance in rodents (124) and is now in clinical trials (125).”
BackgroundSelf-citationIntrahepatic Diacylglycerol Content Is Associated With Hepatic Insulin Resistance in Obese Subjects
Magkos, F., Su, X., Bradley, D., Fabbrini, E., Conte, C., Eagon, J. C., Varela, J. E., Brunt, E. M., Patterson, B. W., & Klein, S. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.03.003 · Cited by 224 · cited 2×
“also demonstrated that hepatic DAG content (but not hepatic ceramide content) was the best predictor of hepatic insulin resistance in obese humans (71).”
BackgroundHaas, J. T., Miao, J., Chanda, D., Wang, Y., Zhao, E., Haas, M. E., Hirschey, M., Vaitheesvaran, B., Farese, R. V., Kurland, I. J., et al. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.05.002 · Cited by 210 · cited 1×
“Both increase SREBP1c expression even in the absence of insulin (111), though insulin action may be necessary for full SREBP1c processing to realize the maximal conversion of these sugars into lipids (112).”
BackgroundInitial splanchnic extraction of ingested glucose in normal man
Radziuk, J., McDonald, T. J., Rubenstein, D., & Dupre, J. (1978) · Metabolism · doi:10.1016/0026-0495(78)90003-3 · Cited by 207
Francois, M. E., Baldi, J. C., Manning, P. J., Lucas, S. J. E., Hawley, J. A., Williams, M. J. A., & Cotter, J. D. (2014) · Diabetologia · doi:10.1007/s00125-014-3244-6 · Cited by 204 · cited 1×
“Even short (6-minute) bursts of exercise prior to meals can significantly improve the diurnal glucose excursion (121).”
BackgroundNagai, Y., Yonemitsu, S., Erion, D. M., Iwasaki, T., Stark, R., Weismann, D., Dong, J., Zhang, D., Jurczak, M. J., Löffler, M. G., et al. (2009) · Cell Metabolism · doi:10.1016/j.cmet.2009.01.011 · Cited by 203
Self-citationGlucose toxicity and the development of diabetes in mice with muscle-specific inactivation of GLUT4
Kim, J. K., Zisman, A., Fillmore, J. J., Peroni, O. D., Kotani, K., Perret, P., Zong, H., Dong, J., Kahn, C. R., Kahn, B. B., et al. (2001) · Journal of Clinical Investigation · doi:10.1172/jci10294 · Cited by 202 · cited 1×
“This has been observed in genetic mouse models of selective muscle insulin resistance due to muscle-specific deletions of the IRTK (27) and GLUT4 (60), which are prone to hepatic steatosis (61) and increased adiposity (27).”
BackgroundSelf-citationMatsuzaka, T., Shimano, H., Yahagi, N., Amemiya-Kudo, M., Okazaki, H., Tamura, Y., Iizuka, Y., Ohashi, K., Tomita, S., Sekiya, M., et al. (2004) · Diabetes · doi:10.2337/diabetes.53.3.560 · Cited by 197 · cited 1×
“Both increase SREBP1c expression even in the absence of insulin (111), though insulin action may be necessary for full SREBP1c processing to realize the maximal conversion of these sugars into lipids (112).”
BackgroundRabøl, R., Petersen, K. F., Dufour, S., Flannery, C., & Shulman, G. I. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1110105108 · Cited by 196 · cited 1×
“Further evidence in support of the key role of substrate in promoting increased hepatic DNL was demonstrated by a study that found that a single bout of elliptical training resulted in increased postprandial muscle glycogen synthesis and reduced hepatic DNL without altering plasma insulin concentrations in healthy, yo…”
BackgroundSelf-citationLeptin reverses diabetes by suppression of the hypothalamic-pituitary-adrenal axis
Perry, R. J., Zhang, X.-M., Zhang, D., Kumashiro, N., Camporez, J.-P. G., Cline, G. W., Rothman, D. L., & Shulman, G. I. (2014) · Nature Medicine · doi:10.1038/nm.3579 · Cited by 193
Self-citationFunctional cloning of TUG as a regulator of GLUT4 glucose transporter trafficking
Bogan, J. S., Hendon, N., McKee, A. E., Tsao, T.-S., & Lodish, H. F. (2003) · Nature · doi:10.1038/nature01989 · Cited by 188
Hwang, J. H., Perseghin, G., Rothman, D. L., Cline, G. W., Magnusson, I., Petersen, K. F., & Shulman, G. I. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117727 · Cited by 177 · cited 1×
“The importance of insulin is seen in patients with type 1 diabetes (T1D), who only synthesize one-third the amount of hepatic glycogen as control subjects after a mixed meal (2).”
BackgroundSelf-citationBrown, J. M., Betters, J. L., Lord, C. C., Ma, Y., Han, X., Yang, K., Alger, H. M., Melchior, J., Sawyer, J. K., Shah, R., et al. (2010) · Journal of Lipid Research · doi:10.1194/jlr.m010256 · Cited by 170 · cited 1×
“Decreasing expression of comparative gene identification-58 (CGI-58), an activator of adipose triglyceride lipase (ATGL), led to marked hepatic steatosis and an increase in total DAG content without hepatic insulin resistance (72).”
BackgroundSelf-citationGerman, J. P., Thaler, J. P., Wisse, B. E., Oh-I, S., Sarruf, D. A., Matsen, M. E., Fischer, J. D., Taborsky, G. J., Schwartz, M. W., & Morton, G. J. (2011) · Endocrinology · doi:10.1210/en.2010-0890 · Cited by 169
NF-κB is important for TNF-α-induced lipolysis in human adipocytes
Jurga, L., Vanessa, V. H., Elisabet, A. N., Andrea, D., Lennart, B., Erik, N., Dominique, L., Peter, A., & Mikael, R. (2007) · Journal of Lipid Research · doi:10.1194/jlr.m600471-jlr200 · Cited by 167
Pulsatile Portal Vein Insulin Delivery Enhances Hepatic Insulin Action and Signaling
Matveyenko, A. V., Liuwantara, D., Gurlo, T., Kirakossian, D., Dalla Man, C., Cobelli, C., White, M. F., Copps, K. D., Volpi, E., Fujita, S., et al. (2012) · Diabetes · doi:10.2337/db11-1462 · Cited by 163 · cited 1×
“The pattern of insulin delivery may also impact Akt phosphorylation, with pulsatile portal delivery (which better mimics physiology) leading to greater activation than continuous, fixed insulin delivery (9).”
BackgroundCantley, J. L., Yoshimura, T., Camporez, J. P. G., Zhang, D., Jornayvaz, F. R., Kumashiro, N., Guebre-Egziabher, F., Jurczak, M. J., Kahn, M., Guigni, B. A., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1219456110 · Cited by 161 · cited 1×
“However, loss of CGI-58 altered the subcellular distribution of DAG and PKCε; specifically, CGI-58 knockdown prevented DAG accumulation at the plasma membrane, PKCε activation, and the associated impairments in hepatic insulin action (73).”
BackgroundSelf-citationCirculating Palmitoleate Strongly and Independently Predicts Insulin Sensitivity in Humans
Stefan, N., Kantartzis, K., Celebi, N., Staiger, H., Machann, J., Schick, F., Čegan, A., Elcnerova, M., Schleicher, E. D., Fritsche, A., et al. (2009) · Diabetes Care · doi:10.2337/dc09-0544 · Cited by 159 · cited 1×
“Adipocytes release specific fatty acids that are associated with increased insulin sensitivity, like palmitoleate (86, 87) or monomethyl branched chain fatty acids (88).”
BackgroundLeptin Deficiency Causes Insulin Resistance Induced by Uncontrolled Diabetes
German, J. P., Wisse, B. E., Thaler, J. P., Oh-I, S., Sarruf, D. A., Ogimoto, K., Kaiyala, K. J., Fischer, J. D., Matsen, M. E., Taborsky, G. J., et al. (2010) · Diabetes · doi:10.2337/db09-1918 · Cited by 159
Stimulating Effects of Low-Dose Fructose on Insulin-Stimulated Hepatic Glycogen Synthesis in Humans
Petersen, K. F., Laurent, D., Yu, C., Cline, G. W., & Shulman, G. I. (2001) · Diabetes · doi:10.2337/diabetes.50.6.1263 · Cited by 153
Self-citationFatty acid-inducible ANGPTL4 governs lipid metabolic response to exercise
Catoire, M., Alex, S., Paraskevopulos, N., Mattijssen, F., Evers-van Gogh, I., Schaart, G., Jeppesen, J., Kneppers, A., Mensink, M., Voshol, P. J., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1400889111 · Cited by 150 · cited 1×
“, single-leg cycling), there is a PPARδ-regulated induction of angiopoietin like-4 (ANGPLT4, an inhibitor of LpL) in the nonexercising muscle matched with a concurrent AMPK-mediated suppression of ANGPLT4 in the exercising muscle (39).”
BackgroundPanarotto, D., Rémillard, P., Bouffard, L., & Maheux, P. (2002) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.2002.00945.x · Cited by 137
FGF1 and FGF19 reverse diabetes by suppression of the hypothalamic–pituitary–adrenal axis
Perry, R. J., Lee, S., Ma, L., Zhang, D., Schlessinger, J., & Shulman, G. I. (2015) · Nature Communications · doi:10.1038/ncomms7980 · Cited by 132 · cited 1×
“It bears noting that adipocytes are exquisitely sensitive to insulin and even low concentrations will trump the effect of hypercorticosteronemia (107).”
BackgroundSelf-citationSynergistic regulation of phosphorylase a by glucose and caffeine.
Kasvinsky, P. J., Shechosky, S., & Fletterick, R. J. (1978) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)34291-6 · Cited by 117
Qu, X., Seale, J. P., & Donnelly, R. (1999) · Journal of Endocrinology · doi:10.1677/joe.0.1620207 · Cited by 116 · cited 1×
“In fat-fed rats, the increase in hepatic DAG content activates PKCε, the primary PKC isoform in liver (66, 67).”
BackgroundMolecular Characterization of Insulin-Mediated Suppression of Hepatic Glucose Production In Vivo
Ramnanan, C. J., Edgerton, D. S., Rivera, N., Irimia, J. M., Farmer, B., Neal, D. W., Lautz, M., Donahue, E. P., Meyer, C. M., Roach, P. J., et al. (2010) · Diabetes · doi:10.2337/db09-1625 · Cited by 114
13C/31P NMR studies on the mechanism of insulin resistance in obesity.
Petersen, K. F., Hendler, R., Price, T. B., Perseghin, G., Rothman, D. L., Held, N., Amatruda, J. M., & Shulman, G. I. (1998) · Diabetes · doi:10.2337/diabetes.47.3.381 · Cited by 109 · cited 1×
“Similar reductions in glucose transport were observed in insulin-resistant, obese individuals (46); patients with T2D (47); and lean, normoglycemic but insulin-resistant offspring of T2D parents (48).”
BackgroundSelf-citationAdiponectin knockout mice on high fat diet develop fibrosing steatohepatitis
Asano, T., Watanabe, K., Kubota, N., Gunji, T., Omata, M., Kadowaki, T., & Ohnishi, S. (2009) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2009.06039.x · Cited by 104 · cited 1×
“Mice lacking adiponectin are prone to hepatic steatosis and hepatic insulin resistance (91, 92).”
BackgroundSu, X., Magkos, F., Zhou, D., Eagon, J. C., Fabbrini, E., Okunade, A. L., & Klein, S. (2014) · Obesity · doi:10.1002/oby.20923 · Cited by 92 · cited 1×
“Adipocytes release specific fatty acids that are associated with increased insulin sensitivity, like palmitoleate (86, 87) or monomethyl branched chain fatty acids (88).”
BackgroundA Noncanonical, GSK3-Independent Pathway Controls Postprandial Hepatic Glycogen Deposition
Wan, M., Leavens, K. F., Hunter, R. W., Koren, S., von Wilamowitz-Moellendorff, A., Lu, M., Satapati, S., Chu, Q., Sakamoto, K., Burgess, S. C., et al. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.06.001 · Cited by 87 · cited 3×
“Recent studies challenge the primacy of the Akt/GSK3β/ glycogen synthase branch in the regulation of glycogen synthesis (10).”
BackgroundInfluentialThe Role of the Carbohydrate Response Element-Binding Protein in Male Fructose-Fed Rats
Erion, D. M., Popov, V., Hsiao, J. J., Vatner, D. F., Mitchell, K. A., Yonemitsu, S., Nagai, Y., Kahn, M., Gillum, M. P., Dong, J., et al. (2012) · Endocrinology · doi:10.1210/en.2012-1725 · Cited by 86 · cited 6×
“Glucose entry into adipose cells activates carbohydrate response element binding protein (ChREBP), which may impact adipose lipid metabolism (85).”
BackgroundInfluentialSelf-citationMorino, K., Petersen, K. F., Sono, S., Choi, C. S., Samuel, V. T., Lin, A., Gallo, A. E., Zhao, H., Kashiwagi, A., Goldberg, I. J., et al. (2012) · Diabetes · doi:10.2337/db11-1391 · Cited by 83 · cited 1×
“In contrast to aging, these reductions in mitochondrial activity appear to be secondary to reduction in mitochondrial density (54) and may be due in part to diminished expression of LpL in skeletal muscle, which could limit PPARδ-mediated mitochondrial biogenesis (55).”
BackgroundSelf-citationRanjit, S., Boutet, E., Gandhi, P., Prot, M., Tamori, Y., Chawla, A., Greenberg, A. S., Puri, V., & Czech, M. (2010) · Journal of Lipid Research · doi:10.1194/jlr.m008771 · Cited by 79 · cited 1×
“Additionally, TNFα, IL-1β, and IFNγ decrease expression of fat-specific protein 27 (FSP27) (100), which may stabilize lipid droplets by controlling lipase access to triglycerides.”
BackgroundRaddatz, K., Turner, N. A., Frangioudakis, G., Liao, B. M., Pedersen, D. J., Cantley, J., Wilks, D. L., Preston, E., Hegarty, B. D., Leitges, M., et al. (2011) · Diabetologia · doi:10.1007/s00125-011-2073-0 · Cited by 79 · cited 1×
“Similarly, Prkce–/– mice are protected from diet-induced insulin resistance following one week of high-fat feeding, despite increases in liver lipid content (69).”
BackgroundShort Term Voluntary Overfeeding Disrupts Brain Insulin Control of Adipose Tissue Lipolysis
Scherer, T., Lindtner, C., Zieliński, E., O’Hare, J., Filatova, N., & Buettner, C. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.307348 · Cited by 73
Ng, J. M., Azuma, K., Kelley, C. A., Pencek, R., Rádiková, Ž., Laymon, C. M., Price, J. C., Goodpaster, B. H., & Kelley, D. E. (2012) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00282.2012 · Cited by 71
The Relation of Insulin to Liver Metabolism
Levine, R., & Fritz, I. B. (1956) · Diabetes · doi:10.2337/diab.5.3.209 · Cited by 70
Bindesbøll, C., Fan, Q., Nørgaard, R. C., MacPherson, L., Ruan, H., Wu, J., Pedersen, T. Å., Steffensen, K. R., Yang, X., Matthews, J. B., et al. (2015) · Journal of Lipid Research · doi:10.1194/jlr.m049130 · Cited by 68
Willecke, F., Scerbo, D. A., Nagareddy, P. R., Obunike, J. C., Barrett, T. J., Abdillahi, M., Trent, C. M., Huggins, L. A., Fisher, E. A. A., Drosatos, K., et al. (2014) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.114.304615 · Cited by 66 · cited 2×
“Consistent with this hypothesis, mice overexpressing skeletal muscle LpL were protected from the hypertriglyceridemia seen with streptozotocin treatment, demonstrating that the creation of a tissue depot for lipids could alter lipid storage and prevent hyperlipidemia (108).”
BackgroundEndoproteolytic Cleavage of TUG Protein Regulates GLUT4 Glucose Transporter Translocation
Bogan, J. S., Rubin, B. R., Yu, C., Löffler, M. G., Orme, C. M., Belman, J., McNally, L. J., Hao, M., & Cresswell, J. A. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.339457 · Cited by 66
Intranasal Insulin Suppresses Systemic but Not Subcutaneous Lipolysis in Healthy Humans
Iwen, K. A., Scherer, T., Heni, M., Sayk, F., Wellnitz, T., Machleidt, F., Preissl, H., Häring, H.-U., Fritsche, A., Lehnert, H., et al. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-3169 · Cited by 59
PNPLA3 variant I148M is associated with altered hepatic lipid composition in humans
Peter, A., Kovářová, M., Nadalin, S., Cermak, T., Königsrainer, A., Machicao, F. E., Stefan, N., Häring, H., & Schleicher, E. D. (2014) · Diabetologia · doi:10.1007/s00125-014-3310-0 · Cited by 55
A critical evaluation of mass isotopomer distribution analysis of gluconeogenesis in vivo
Previs, S. F., Cline, G. W., & Shulman, G. I. (1999) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1999.277.1.e154 · Cited by 52 · cited 1×
“Second, by inhibiting lipolysis, insulin curtailed glycerol delivery to the liver and reduced conversion of glycerol to glucose (18, 19).”
BackgroundSelf-citationBézaire, V., Mairal, A., Anesia, R., Lefort, C., & Langin, D. (2009) · FEBS Letters · doi:10.1016/j.febslet.2009.08.019 · Cited by 51 · cited 1×
“TNFα lowers perilipin expression, presumably enhancing lipolysis (98, 99).”
BackgroundGriffith, D. A., Dow, R. L., Huard, K., Edmonds, D. J., Bagley, S. W., Polívková, J., Zeng, D., García-Irizarry, C. N., Southers, J. A., Esler, W. P., et al. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm401033t · Cited by 49
Visceral obesity modulates the impact of apolipoprotein C3 gene variants on liver fat content
Peter, A., Kantartzis, K., Machicao, F. E., Machann, J., Wagner, S., Templin, S., Königsrainer, I., Königsrainer, A., Schick, F., Fritsche, A., et al. (2011) · International Journal of Obesity · doi:10.1038/ijo.2011.154 · Cited by 42 · cited 1×
“Recently, polymorphisms in APOC3 were shown to predispose lean, male individuals to NAFLD and insulin resistance (94, 95).”
BackgroundCostabile, G., Annuzzi, G., Marino, L., Natale, C. D., Giacco, R., Bozzetto, L., Cipriano, P., Santangelo, C., Masella, R., & Rivellese, A. A. (2011) · Journal of Endocrinological Investigation · doi:10.1007/bf03347469 · Cited by 32
Enhanced Fasting Glucose Turnover in Mice with Disrupted Action of TUG Protein in Skeletal Muscle
Löffler, M. G., Birkenfeld, A. L., Philbrick, K. M., Belman, J., Habtemichael, E. N., Booth, C. J., Castorena, C. M., Choi, C. S., Jornayvaz, F. R., Gassaway, B. M., et al. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.458075 · Cited by 29
Self-citationHepatic glucose uptake and disposition during short-term high-fat vs. high-fructose feeding
Coate, K. C., Kraft, G., Moore, M. C., Smith, M. S., Ramnanan, C. J., Irimia, J. M., Roach, P. J., Farmer, B., Neal, D. W., Williams, P., et al. (2014) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00083.2014 · Cited by 22 · cited 1×
“Coate and colleagues demonstrated that dogs fed a high-fat diet or high-fructose diet for four weeks developed a similar degree of insulin resistance (77).”
Background
Research works printed but not linked: 6
- 10.1210/jcem.87.8.8761 · doi:10.1210/jcem.87.8.8761 · Paper page
- Kersten, 2014, Physiological regulation of lipoprotein lipase, Biochim Biophys Acta, 1841, 919, 10.1016/j.bbalip.2014.03.013 · DOI · Paper page
- 10.1172/JCI10294 · DOI · Paper page
- 10.1172/JCI15001 · doi:10.1172/jci15001 · Paper page
- 10.1172/JCI19246 · doi:10.1172/jci19246 · Paper page
- 10.1172/JCI19451 · doi:10.1172/jci19451 · Paper page
Cited by
Mechanisms of NAFLD development and therapeutic strategies
Friedman, S. L., Neuschwander-Tetri, B. A., Rinella, M., & Sanyal, A. J. (2018) · Nature Medicine · doi:10.1038/s41591-018-0104-9 · Cited by 4,354
Mechanisms of Insulin Action and Insulin Resistance
Petersen, M. C., & Shulman, G. I. (2018) · Physiological Reviews · doi:10.1152/physrev.00063.2017 · Cited by 3,028
Self-citationAssociation between insulin resistance and the development of cardiovascular disease
Ormazabal, V., Nair, S., Elfeky, O., Aguayo, C., Salomon, C., & Zuñiga, F. A. (2018) · Cardiovascular Diabetology · doi:10.1186/s12933-018-0762-4 · Cited by 2,280
Inflammation in obesity, diabetes, and related disorders
Rohm, T. V., Meier, D. T., Olefsky, J. M., & Donath, M. Y. (2022) · Immunity · doi:10.1016/j.immuni.2021.12.013 · Cited by 2,066
Diabetic Cardiomyopathy: An Update of Mechanisms Contributing to This Clinical Entity
Jia, G., Hill, M. A., & Sowers, J. R. (2018) · Circulation Research · doi:10.1161/circresaha.117.311586 · Cited by 1,807
“obese humans can be correlated to elevated diacylglycerol content and PKC ε (protein kinase Cε) activation.(60) Diacylglycerol increases lipid-associated endoplasmic reticulum stress.”
Background
Metadata
- Authors
- Samuel, V. T., & Shulman, G. I.
- Affiliations
- Veterans Health Administration (US)
- Howard Hughes Medical Institute (US)
- Venue
- Journal of Clinical Investigation
- Published
- 2016-01-04
- Volume
- 126
- Issue
- 1
- Pages
- 12-22
- ISSN
- 0021-9738 (ISSN-L)
- 1558-8238
- PMC
- PMC4701542
- OpenAlex
- W2230222215
- Cited by
- 1,484
- References
- 131
- Citations by year
- 2026: 192 · 2025: 162 · 2024: 152 · 2023: 150 · 2022: 150 · 2021: 143 · 2020: 134 · 2019: 136 · 2018: 114 · 2017: 99 · 2016: 51
- FWCI
- 18.06
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- U.S. Department of Veterans Affairs (I01 BX000901)
- National Institute of Diabetes and Digestive and Kidney Diseases (DK-49230, R01DK049230, DK40936, DK 45735, R01DK040936, U24DK059635, R24DK085638, DK059635, DK-085638, P30DK045735)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- insulin resistance, type 2 diabetes, ectopic fat deposition, hepatic insulin signaling, skeletal muscle glucose uptake, hepatic gluconeogenesis, hepatic de novo lipogenesis, adipose tissue lipolysis, hepatic triglyceride synthesis, fatty acid esterification, hyperlipidemia, hyperglycemia, pyruvate carboxylase, acetyl-CoA, substrate flux, inflammation, energy surplus
- MeSH terms
- Adipose Tissue, Animals, Glucose, Humans, Insulin Resistance, Liver, Triglycerides, Signal Transduction, Muscle, Skeletal, Lipid Metabolism
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.